Company / Capital Returned to Shareholders per Share
Charles River Laboratories Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$7.33
FY2025
5-year range
$0.36 / $7.33
FY2021-FY2025
Trend
+215.7%
vs FY2024
Sector context
#20 of 108
Health Care
What the data says
Capital Returned to Shareholders per Share changed +216% YoY in FY2025, a notable deviation from the 9-year average annual change of +198%.
Based on SEC 10-K filings.
7.33 in FY2025 with a 5-year CAGR of +91.7%. Top quartile in the Health Care sector.
Improved from $0.80 to $7.33 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +148.9%
- 5-Year CAGR
- +91.7%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 108This company $7.33 Sector average $5.07
▼
+44.5% above sector average
Key checks
Key Insights
- Charles River Laboratories's capital returned to shareholders per share has grown for 5 consecutive years.
- In FY2025, capital returned to shareholders per share increased 215.7% year-over-year.
- Ranks #20 out of 108 companies in the Health Care sector.
- Lowest capital returned to shareholders per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.33 | +215.7% |
| FY2024 | $2.32 | +190.5% |
| FY2023 | $0.80 | +68.2% |
| FY2022 | $0.48 | +30.7% |
| FY2021 | $0.36 | +28.4% |
| FY2020 | $0.28 | -87.2% |
| FY2019 | $2.22 | +659.2% |
| FY2018 | $0.29 | -87.1% |
| FY2017 | $2.26 | +759.3% |
| FY2016 | $0.26 | -92.5% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026